Navigation

NEWS RELEASES

Search all of our news releases here.

Search
Generic filters

Try these: Jeff GalvinHIVFDAAmerican Gene Technologies

AGT Granted Fifth Patent Protecting Its Immunotherapy Cancer Cure Asset

AGT Granted Fifth Patent Protecting Its Immunotherapy Cancer Cure Asset

Mar 21, 2019

ROCKVILLE, MD, UNITED STATES, March 21, 2019 /EINPresswire.com/ — American Gene Technologies (AGT) recently was awarded a fifth immuno-oncology patent (“Methods and Composition for the Activation of Gamma Delta T cells” US10137144) to protect its lead asset in immunotherapy for cancer. This patent further validates the advances AGT… [Read More]

Second Patient Cured of HIV and The Implications for American Gene Technologies's AGT103-T

Second Patient Cured of HIV and The Implications for American Gene Technologies’s AGT103-T

Mar 9, 2019

ROCKVILLE, MD, UNITED STATES, March 8, 2019 / American Gene Technologies (AGT) is pleased to see the release of information about a second individual cured of HIV in London–recently reported in the Wall Street Journal and New York Times. The patient was treated with a… [Read More]

American Gene Technologies Signs Research Agreement with NIAID for Experimental HIV/AIDS Cure Strategy

American Gene Technologies Signs Research Agreement with NIAID for Experimental HIV/AIDS Cure Strategy

Feb 14, 2019

AGT signed Research Collaboration Agreement with National Institute of Allergy and Infectious Diseases for studies on AGT’s cell and gene therapy for HIV/AIDS. ROCKVILLE, MD, UNITED STATES, February 14, 2019 /EINPresswire.com/ — American Gene Technologies (AGT) recently signed a Research Collaboration Agreement with the National… [Read More]

American Gene Technologies To Attend 2019 J.P. Morgan Healthcare Conference

American Gene Technologies To Attend 2019 J.P. Morgan Healthcare Conference

Jan 7, 2019

ROCKVILLE, MD, UNITED STATES, January 7, 2019 /EINPresswire.com/ — American Gene Technologies announced today that its Chief Executive Officer, Jeff Galvin, will attend the annual J.P. Morgan Healthcare Conference, held at the Westin St. Francis between January 7-10 in San Francisco, California. American Gene Technologies invitation to attend the… [Read More]

American Gene Technologies Granted FDA Orphan Drug Designation For Phenylketonuria

Oct 18, 2018

ROCKVILLE, MD, UNITED STATES, October 18, 2018 /EINPresswire.com/ — American Gene Technologies (AGT), a leading gene and cell therapy company in the discovery and development of lentiviral vector based therapeutics, announces that the U.S. Food and Drug Administration (FDA) received orphan-drug designation #DRU-2018-6572 for the treatment… [Read More]

American Gene Technologies to Present at 2018 Cell and Gene Meeting On The Mesa

Sep 26, 2018

ROCKVILLE, MD, UNITED STATES, September 26, 2018 /EINPresswire.com/ — American Gene Technologies announced today that its Chief Science Officer C. David Pauza, Ph.D. will present at the annual Partnering Forum, part of the Cell & Gene Meeting on the Mesa to be held October 3-5 in La Jolla, California…. [Read More]

Immunotherapy CEO Jeff Galvin Joins The Board of Directors of the Cancer Support Community

Sep 6, 2018

ROCKVILLE, MD, UNITED STATES, September 6, 2018 /EINPresswire.com/ — Jeff Galvin, a former Silicon Valley CEO, and now a leader in the field of gene and cell therapy to cure cancer and other human diseases, has joined the Board of Directors of the Cancer Support Community (CSC)…. [Read More]

American Gene Technologies (AGT) Granted Three New Patents in its HIV Cure and Immuno-oncology Programs

Aug 22, 2018

ROCKVILLE, MD, UNITED STATES, August 22, 2018 /EINPresswire.com/ — AGT announces the receipt of three foundational patents. Two new patents focus on the immuno-oncology program and add to AGT’s broad protection for its unique process of activating gamma delta T cells to attack solid tumors… [Read More]

American Gene Technologies CEO Jeff Galvin Joins Maryland Tech Council Board of Directors

Aug 20, 2018

ROCKVILLE, MD, UNITED STATES, August 20, 2018 /EINPresswire.com/ — American Gene Technologies International Inc. (AGT)’s CEO and founder Jeff Galvin has been appointed to the Board of Directors of the Maryland Tech Council, the largest Maryland technology trade association, representing over 600 companies across the… [Read More]

American Gene Technologies Congratulates Robert Redfield, M.D., on His Appointment as Director of the Centers for Disease Control and Prevention

Apr 30, 2018

ROCKVILLE, Md., March 28, 2018 (GLOBE NEWSWIRE) — American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today congratulates Robert R. Redfield, M.D., on his appointment as the Director of the Centers for Disease Control and Prevention (CDC). Dr. Redfield has served as… [Read More]

Subscribe to News Releases and News Updates

Subscribe to our news release and published article updates to be notified when we release new content!

Follow AGT on Social Media